Search results
FDA report highlights need to improve diversity in clinical trials
Clinical Trials Arena via Yahoo Finance· 8 hours agoThe US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) is...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
KSBW Salinas· 18 minutes agoTwo health care businesses – biotechnology company Roche and medical technology firm Becton, Dickson...
Earnings call: Movano Health Q1 2024 earnings focus on Evie Ring, FDA progress By Investing.com
Investing.com· 5 hours agoThe company showcased the ongoing development of its Evie Ring, a key product in its portfolio, and...
FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously...
Benzinga· 3 hours agoWednesday, the FDA granted accelerated approval to Bristol Myers Squibb Co’s BMY Breyanzi...
...Keeping Track of Your Data — What You Need to Know about FDA’s Draft Guidance on Data Integrity...
JD Supra· 12 hours agoGiven data integrity issues that have been uncovered in the past, in April 2024, the U.S. Food and Drug Administration (FDA) published a draft guidance to applicants and testing ...
Council Post: The Business Case For Expanding Diversity In Clinical Trials
Forbes· 14 hours agoBy now, you’ve heard why expanding representation in clinical trial populations matters for health...
Q1 2024 Abeona Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 hours agoVasanthavada Thank you, Vish. We remain confident in the potential of Pz-cel as a game-changing therapy for our patients. And our momentum towards commercial readiness continues. Because the ...
Exploring the latest trends in clinical trials: A glimpse into the future
Nutraingredients.com· 9 hours agoThis type of trial involves randomly assigning participants to two or more groups (an experimental group and a control group) and comparing the outcomes of the groups to determine ...
Earnings call: Zealand Pharma reports solid Q1 results, advances in obesity treatment
Investing.com· 14 hours agoCEO Adam Steensberg highlighted the company's satisfaction with its financial performance in the...
Earnings call: Know Labs bolsters R&D for non-invasive glucose monitor By Investing.com
Investing.com· 3 hours agoIn a recent earnings call, Know Labs reported a total revenue of $50,000 for the quarter, primarily...
